227. オスラー病 Osler disease Clinical trials / Disease details

臨床試験数 : 56 / 薬物数 : 72 - (DrugBank : 21) / 標的遺伝子数 : 23 - 標的パスウェイ数 : 136

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02874326 (ClinicalTrials.gov)	October 2016	17/8/2016	Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber	An Uncontrolled, Pilot-study Assessing the Efficacy of Octreotide Long-acting Release to Decrease Tr ...	Hereditary Hemorrhagic Telangiectasia;Gastrointestinal Hemorrhage;Anemia	Drug: Octreotide LAR	Radboud University	St. Antonius Hospital	Unknown status	18 Years	N/A	All	15	Phase 2	Netherlands
2	EUCTR2016-001340-19-NL (EUCTR)	21/07/2016	11/07/2016	The effectiveness of the drug octreotide LARto anemia in patients with gastrointestinal bleeding due ...	An uncontrolled, pilot-study assessing the efficacy of octreotide LARto decrease transfusion require ...	Patients with Rendu-Osler-Weber disease (which is also called: Hereditary hemorrhagic telangiectasia ...	Trade Name: Sandostatin LAR 20 mg Product Name: Sandostatin LAR Product Code: RVG 18236	Radboud University Medical Center	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 2	Netherlands

First Previous1Next Last